Zezos P, Saibil F. Inflammatory pouch disease: The spectrum of pouchitis. World J Gastroenterol 2015; 21(29): 8739-8752 [PMID: 26269664 DOI: 10.3748/wjg.v21.i29.8739]
Corresponding Author of This Article
Petros Zezos, MD, PhD, Division of Gastroenterology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, H52-2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. zezosp13@hotmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 2 The variety of idiopathic pouchitis classifications
Activity
Active
Inactive
Presentation
Acute < 4 wk duration
Chronic > 4 wk duration
Clinical pattern
Single episode
Infrequent < 4 episodes a year
Relapsing > 4 episodes a year
Continuous
Response to treatment
Responsive
Refractory
Response to antibiotics
Antibiotic-responsive:
Infrequent episodes (< 4 episodes per year) responding to a 2-wk course of a single antibiotic
Antibiotic-dependent
Frequent episodes or persistent episodes of pouchitis requiring long-term, continuous therapy for maintaining remission
Chronic antibiotic-refractory
Not responding to a 4-wk course of metronidazole or ciprofloxacin, requiring prolonged therapy of ≥ 4 wk consisting of 2 or more antibiotics, oral or topical 5-ASA, corticosteroids, AZA/6-MP, or biologics